Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic responseAmir Fathi, Yi‐Bin Chen, Hossein Sadrzadeh et al.|Blood|2012Cited by 123
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Maria R. Baer, Vu H. Duong et al.|Leukemia & lymphoma/Leukemia and lymphoma|2013Cited by 56
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemiaAshkan Emadi, Søren M. Bentzen, Jennie Y. Law et al.|Cancer Chemotherapy and Pharmacology|2017Cited by 53
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic TransplantationKeith W. Pratz, Mark J. Levis, Michelle A. Rudek et al.|Transplantation and Cellular Therapy|2019Cited by 43
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and managementNajeebah A. Bade, Ashkan Emadi, Crystal Lu et al.|Journal of Oncology Pharmacy Practice|2019Cited by 42